Pfizer
Rowena Vinci is an accomplished professional in talent acquisition, currently serving as the Global Talent Acquisition Leader at Pfizer Global Supply. With significant experience in senior roles, Rowena has previously held positions such as Sr. Director of Global Talent Acquisition at Clario and Head of Leadership and Professional Talent Acquisition for North America at Nestlé Waters. Additional expertise includes serving as Talent Acquisition Lead for Corporate Functions at PepsiCo and HR & Operations Manager at Peebles GmbH, a global business consulting company. Rowena's educational background includes studies at De La Salle University and completion of a program at Ateneo Graduate School of Business from 2007 to 2008.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.